The SLAS International Conference and Exhibition is the flagship annual conference and exhibition presented by SLAS and the must-attend event dedicated to life sciences discovery and laboratory automation technology. Schedule...
Now in its 21st year, Advanced Therapies Week is the premier biotech partnering event in the United States. Bringing together leaders in research, therapeutic development, and advanced manufacturing. Join us...
IO360° Delivers 4 Key Benefits 1.Delivering a 360° IO Community to Network and Form Collaborations Build faster and more impactful collaborations with researchers, clinicians, biopharma leaders, investors and policymakers...
Join Bioprocess Online Chief Editor Tyler Menichiello on February 11, at 11 a.m. Eastern, for an interactive panel discussion exploring how upstream and downstream development teams can work together to...
Watch leading CDMOs share their current capabilities, facility locations, and timelines—helping you identify the right partners for your small molecule drug product development and manufacturing needs. What to expect: -...
Watch leading CDMOs share their current capabilities, facility locations, and timelines—helping you identify the right partners for your cell and gene development and manufacturing needs. Explore the fast-growing field of...
Join us at the Houston Life Sciences Commercial Real Estate Conference, where researchers, developers, investors, and real estate professionals converge to examine the forces shaping one of the fastest-growing innovation hubs...
In this Capabilities Update, industry leaders will share where AI is delivering value today—from hit-to-lead optimization and analytical method development to model-informed process development and digital CPV/QMS—and how CDMOs and...
2026 marks a turning point in life sciences — the year AI moves from concept to core capability. With ELaiN, the world’s first AI-native ELN, Sapio is leading this transformation, making software...
As life sciences manufacturers progress along their digital maturity journey, validation data is increasingly recognized as a strategic asset rather than a compliance artifact. In this session, experts will illustrate...
Ultrafiltration/Diafiltration (UF/DF) processes that look robust at the development scale often expose critical weaknesses during scale-up or tech transfer—resulting in capacity constraints, excessive manual intervention, delayed timelines, or manufacturing risk....
Back By Popular Demand! Our third Clinical Leader Live on AI will go beyond the buzzwords to focus on what’s actually working in clinical operations. You will hear about some...
